PredictImmune Ltd.

https://www.predictimmune.com

Twitter: @predictimmune

LinkedIn: https://www.linkedin.com/company/16299157

	Start	2017-05-01 established
	Industry	biomarker
	Industry 2	diagnostics (medical/biological)
	Person	Sandham, Andrew (Andy) (Abingworth 200601– Venture Partner + Kymab 201007 CEO)

	Region	Cambridge, Cambridgeshire
	Country	United Kingdom (GB)
	Street	270 Maia Building Babraham Research Campus
	City	CB22 3AT Cambridge, Cambridgeshire
	Tel	+44-1223-804195
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2019-09-23

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for PredictImmune Ltd.

[1] PredictImmune Ltd.. (9/19/19). "Press Release: PredictImmune Announces New ‘Framework Agreement’ with Cambridge Enterprise". Cambridge....
[2] PredictImmune Ltd.. (7/30/19). "Press Release: PredictImmune Closes Series B Funding Round, Raising £10M to Further Accelerate Global Commercial Expansion and Support Expanding Product Pipeline". Cambridge....
[3] PredictImmune Ltd.. (4/2/19). "Press Release: PredictImmune’s First Prognostic Test for IBD PredictSURE IBD, Launches in the UK and Ireland". Cambridge....
[4] PredictImmune Ltd.. (4/30/18). "Press Release: PredictImmune Secures £4.3m Investment from Wellcome Trust to Evaluate The Clinical Utility of Its Prognostic Test in Crohn’s Disease". Cambridge....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]